title: Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine.
authors.affiliation: The Cancer Institute of New Jersey and Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ.
authors.forename: Neil K
authors.initials: NK
authors.lastname: Taunk
authors.forename: Bruce G
authors.initials: BG
authors.lastname: Haffty
authors.forename: Sharad
authors.initials: S
authors.lastname: Goyal
mesh_terms: D017311:Amlodipine / Q000008:administration & dosage / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D002278:Carcinoma in Situ / Q000532:radiotherapy; D018270:Carcinoma, Ductal, Breast / Q000532:radiotherapy; D018275:Carcinoma, Lobular / Q000532:radiotherapy; D002481:Cellulitis / Q000175:diagnosis / Q000188:drug therapy; D003937:Diagnosis, Differential; D019583:Dose Fractionation, Radiation; D004334:Drug Administration Schedule; D005260:Female; D005464:Fluorobenzenes / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D015412:Mastectomy, Segmental; D008875:Middle Aged; D009367:Neoplasm Staging; D011743:Pyrimidines / Q000008:administration & dosage / Q000009:adverse effects*; D011855:Radiodermatitis / Q000139:chemically induced* / Q000175:diagnosis*; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects*; D000068718:Rosuvastatin Calcium; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D000959:Antihypertensive Agents; D005464:Fluorobenzenes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; D017311:Amlodipine; D000068718:Rosuvastatin Calcium